USA Today: Conflicts of interest bedevil psychiatric drug research
Psychiatry’s leadership is scrambling and fumbling in its effort to explain why it’s collusion with industry for pay is okay.
Has the Obama administration already cowered to the demands of Big Pharma?
Forbes Magazine reports "How one company turned a rejection into a thumbs up, and what it could mean for the drug industry as a whole."
Title: FDA Approves Antipsychotic With Long History of Failure
The FDA has just approved the anitpsychotic drug, Fanapt (iloperidone) for adults with schizophrenia.
The drug, iloperidone, has a long history of failure. http://en.wikipedia.org/wiki/Iloperidone :
NAMI Acknowledges: 56% of Budget Comes from Drug Companies
In its response to Sen. Grassley’s probe, The National Alliance on Mental Illness (NAMI) acknowledges that a majority of its funds over the last five years, 56% on average, have come from drug corporations.
Institute of Medicine Calls for Doctors to Stop Taking Gifts From Drug Makers
The Institute of Medicine has issued a “scolding,” “stinging,” and “damning” report about financial conflicts of interest in American medicine involving pharmaceutical, medical device, and biotechnology companies.
Does the FDA have the authority to trump the Declaration of Helsinki?
The FDA is sliding rapidly down the slippery slope, abandoning widely accepted, international ethical research standards articulated in the internationally accepted, Declaration of Helsinki–to facilitate commercial medical experiments.
AHRP Letter to Harvard Re: Dr. Biederman’s Research
AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman’s publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies.
Culling the $$$ Evidence: National Alliance for Mental Illness
Grassley’s team has asked NAMI to disclose the specifics of its funding so that people with mental illness and their families, as well as the public and healthcare officials, can see for themselves how conflicted this advocacy group is.
Is the FDA Bipolar or Complicit in Legitimizing IIlegal Marketing?
The FDA expanded approval process for toxic drugs is unaffected by evidence uncovered by the US Justice Department showing the studies to be flawed, if not fraudulent.
Placebo Beat Both Zyprexa & Eli Lilly’s Experimental Drug
The results suggest that the truth may have escaped the usual exclusion criteria. Underlying the commercial success of the new antipsychotics is evidence (usually suppressed) showing that these drugs are both harmful and ineffective even for their approved use.
Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildren
The State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being exposed to the hazardous effects of antipsychotic drugs. That step has prompted "a seismic change" in doctors’ inappropriate prescribing of antipsychotics for preschool children: the number of prescriptions for this age group has…
All Bias, All BULL–Psychiatry Deception Re: ADHD Drugs Benefits_WashPost
ADHD published reports have been carefully crafted to declare pro-drug "conclusions"–but those conclusions are belied by the actual evidence about the long-term effects of ADHD drugs on children’s health.